RegisterLogin

VPC-13789

CAT: 0804-HY-139970Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-139970Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
VPC-13789 is a potent, selective, and orally bioavailable antiandrogen. VPC-13789 can be used for the research of castration-resistant prostate cancer (CRPC) therapeutics. VPC-13789 inhibits androgen receptor (AR) transcriptional activity in LNCaP cells (IC50=0.19 μM) [1].
CAS Number
[2761146-51-2]
UNSPSC
12352005
Target
Androgen Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Endocrinology
Assay Protocol
https://www.medchemexpress.com/vpc-13789.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C2C=CC(C3=CNC4=C3C=C(F)C(F)=C4F)=NC2=CC=C1)NC(C)C
Molecular Formula
C21H16F3N3O
Molecular Weight
383.37
References & Citations
[1]Eric Leblanc , et al. Development of 2- (5,6,7-Trifluoro-1 H-Indol-3-yl) -quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer. J Med Chem. 2021 Oct 28;64 (20) :14968-14982.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-118409VPC-3033
HY-108490-01VPC 23019
HY-120018-01VPC-13566
HY-144878-01VPC-70619
HY-126076A-01VPC-80051
HY-117669-01VPC-14228
HY-147291-01VPC-70063
HY-116501-01VPC-14449
HY-122234-01VPC-18005
HY-126076-01VPC-80051 (racemate)

Alternative Products

CatalogName
T61653-01VPC-13789
MBS3617052-01VPC-18005
MBS3616515-01VPC-13566
MBS3616384-01VPC-14228
T9731-01VPC-70619
MBS5770159VPC 23019
MBS5785987VPC-70063
BA9177-5.1VPC-14449
MBS3616514-01VPC-13163
MBS3602386-01VPC 14449

Popular Products